| Year |
Citation |
Score |
| 2019 |
Ye B, Shi J, Kang H, Oyebamiji O, Hill D, Yu H, Ness S, Ye F, Ping J, He J, Edwards J, Zhao YY, Guo Y. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Rna Biology. PMID 31607216 DOI: 10.1080/15476286.2019.1679585 |
0.341 |
|
| 2019 |
Ping J, Oyebamiji O, Yu H, Ness S, Chien J, Ye F, Kang H, Samuels D, Ivanov S, Chen D, Zhao YY, Guo Y. MutEx: a multifaceted gateway for exploring integrative pan-cancer genomic data. Briefings in Bioinformatics. PMID 31588509 DOI: 10.1093/Bib/Bbz084 |
0.372 |
|
| 2019 |
Sharma ND, Nickl CK, Kang H, Ornatowski W, Brown R, Ness SA, Loh ML, Mullighan CG, Winter SS, Hunger SP, Cannon JL, Matlawska-Wasowska K. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia. Cancer Science. PMID 30974024 DOI: 10.1111/Cas.14021 |
0.313 |
|
| 2019 |
Win KZ, Kang H, Alqam HM, Arana-Yi C. Comparative Analysis for Effectiveness of Azacitidine Versus Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes in New Mexico: A Single Institution Experience Blood. 130: 5028-5028. DOI: 10.1182/Blood-2019-131881 |
0.354 |
|
| 2018 |
Kang H, Sharma ND, Nickl CK, Devidas M, Loh ML, Hunger SP, Dunsmore KP, Winter SS, Matlawska-Wasowska K. Dysregulated transcriptional networks in and -rearranged T-ALL. Biomarker Research. 6: 27. PMID 30159143 DOI: 10.1186/S40364-018-0141-Z |
0.356 |
|
| 2018 |
Frerich CA, Brayer KJ, Painter BM, Kang H, Mitani Y, El-Naggar AK, Ness SA. Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes. Oncotarget. 9: 7341-7358. PMID 29484115 DOI: 10.18632/Oncotarget.23641 |
0.426 |
|
| 2017 |
Wan G, Kang H, Ness S, Greenbam A, Rajput A. Abstract LB-077: H1047R mutation of p110 alpha alters expression level of genes which are associated with cell migration & cancer metastasis Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-077 |
0.371 |
|
| 2016 |
Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CK, Ness SA, Rusch M, Li Y, Onozawa M, Martinez C, Wood BL, Asselin BL, Chen IM, Roberts KG, et al. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study. Leukemia. PMID 26952838 DOI: 10.1038/Leu.2016.60 |
0.327 |
|
| 2016 |
Kang H, Sharma N, Nickl CK, Ness S, Devidas M, Wood BL, Asselin BL, Raetz E, Carroll WL, Winick N, Loh ML, Hunger SP, Heerema NA, Carroll AJ, Dunsmore KP, et al. New Insights into Deregulated Gene Expression Pathways in MLL- and AF10-Rearranged T-Lineage Acute Lymphoblastic Leukemia Blood. 128: 2906-2906. DOI: 10.1182/Blood.V128.22.2906.2906 |
0.394 |
|
| 2016 |
Guenthoer J, Chai X, Makar KW, Carlson CS, Bakkar R, King IB, Kang H, Thompson B, Li CI, Hsu L, Cook LS, Porter PL. Abstract C56: Relationship of ancestry and breast cancer subtypes in Hispanic women from New Mexico and Washington State Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-C56 |
0.32 |
|
| 2015 |
Brayer KJ, Frerich CA, Kang H, Ness SA. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. Cancer Discovery. PMID 26631070 DOI: 10.1158/2159-8290.Cd-15-0859 |
0.349 |
|
| 2015 |
Guo Y, Kenney SR, Cook LS, Adams SF, Rutledge T, Romero E, Oprea T, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG. A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26071482 DOI: 10.1158/1078-0432.Ccr-15-0461 |
0.54 |
|
| 2015 |
Zhang QY, Chabot-Richards D, Evans M, Spengel K, Andrews J, Kang H, Foucar K. A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms. International Journal of Laboratory Hematology. 37: 390-402. PMID 25307888 DOI: 10.1111/Ijlh.12299 |
0.301 |
|
| 2015 |
Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CC, Ness S, Rusch M, Li Y, Onozawa M, Martinez C, Wood BL, Asselin B, Chen IL, Roberts KG, et al. Mixed Lineage Leukemia Rearrangements (MLL-R) Are Determinants of High Risk Disease in Homeobox A (HOXA)-deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Blood. 126: 694-694. DOI: 10.1182/Blood.V126.23.694.694 |
0.391 |
|
| 2014 |
Davies S, Holmes A, Lomo L, Steinkamp MP, Kang H, Muller CY, Wilson BS. High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 33: 402-10. PMID 24901400 DOI: 10.1097/Pgp.0000000000000081 |
0.33 |
|
| 2013 |
Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah MF, Nowak D, Thoennissen GB, Rand V, Graeber TG, Koeffler HP, et al. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. Nature Medicine. 19: 1014-22. PMID 23852341 DOI: 10.1038/Nm.3247 |
0.381 |
|
| 2013 |
Loh ML, Zhang J, Harvey RC, Roberts K, Payne-Turner D, Kang H, Wu G, Chen X, Becksfort J, Edmonson M, Buetow KH, Carroll WL, Chen IM, Wood B, Borowitz MJ, et al. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood. 121: 485-8. PMID 23212523 DOI: 10.1182/Blood-2012-04-422691 |
0.363 |
|
| 2013 |
Harvey RC, Kang H, Roberts KG, Chen IL, Atlas SR, Bedrick EJ, Gastier-Foster JM, Zhang J, Gerhard DS, Smith MA, Larsen EC, Raetz EA, Winick NJ, Carroll WL, Stonerock E, et al. Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“Ph-like” or “BCR-ABL1-Like”) Signature For Therapeutic Targeting and Clinical Intervention Blood. 122: 826-826. DOI: 10.1182/Blood.V122.21.826.826 |
0.612 |
|
| 2012 |
Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 119: 3512-22. PMID 22368272 DOI: 10.1182/Blood-2011-11-394221 |
0.405 |
|
| 2012 |
Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 119: 1872-81. PMID 22210879 DOI: 10.1182/Blood-2011-10-382861 |
0.605 |
|
| 2012 |
Yang JJ, E S, Shen S, Bhojwani D, Kang H, Ma Y, Chen J, Tang J, Seibel NL, Xu H, Cheng J, Ramsey LB, Crews K, Bowman WP, Borowitz MJ, et al. PDE4B Modulates Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia Blood. 120: 530-530. DOI: 10.1182/Blood.V120.21.530.530 |
0.38 |
|
| 2012 |
Swaminathan S, Kang H, Harvey RC, Huang C, Buchner M, Chen Z, Geng H, Hall A, Igarashi K, Carroll WL, Willman CL, Melnick A, Muschen M. BACH2 Is Required for Pre-B Cell Receptor Checkpoint Control and p53-Dependent Tumor Surveillance Blood. 120: 1300-1300. DOI: 10.1182/Blood.V120.21.1300.1300 |
0.39 |
|
| 2011 |
Loh ML, Harvey RC, Mullighan CG, Linda SB, Devidas M, Borowitz MJ, Carroll AJ, Chen I, Gastier-Foster JM, Heerema NA, Kang H, Raetz EA, Roberts KG, Zhang J, Winick N, et al. A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232 Blood. 118: 743-743. DOI: 10.1182/Blood.V118.21.743.743 |
0.453 |
|
| 2010 |
Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 116: 4874-84. PMID 20699438 DOI: 10.1182/Blood-2009-08-239681 |
0.637 |
|
| 2010 |
Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 115: 5312-21. PMID 20139093 DOI: 10.1182/Blood-2009-09-245944 |
0.435 |
|
| 2010 |
Stidley CA, Picchi MA, Leng S, Willink R, Crowell RE, Flores KG, Kang H, Byers T, Gilliland FD, Belinsky SA. Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Research. 70: 568-74. PMID 20068159 DOI: 10.1158/0008-5472.Can-09-3410 |
0.309 |
|
| 2010 |
Kang H, Chen IM, Wilson CS, Bedrick EJ, Harvey RC, Atlas SR, Devidas M, Mullighan CG, Wang X, Murphy M, Ar K, Wharton W, Borowitz MJ, Bowman WP, Bhojwani D, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 115: 1394-405. PMID 19880498 DOI: 10.1182/blood-2009-05-218560 |
0.617 |
|
| 2010 |
Garcia CF, Hunt KE, Kang H, Babb A, Gale JM, Vasef MA, Reichard KK. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 18: 119-27. PMID 19826250 DOI: 10.1097/Pai.0B013E3181Bbd5D5 |
0.357 |
|
| 2010 |
Kang H, Wilson CS, Harvey RC, Chen I, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Heerema NA, Hilden JM, Dreyer ZE, Camitta B, Winick N, et al. Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study Blood. 116: 412-412. DOI: 10.1182/Blood.V116.21.412.412 |
0.614 |
|
| 2008 |
Bhojwani D, Kang H, Menezes RX, Yang W, Sather H, Moskowitz NP, Min DJ, Potter JW, Harvey R, Hunger SP, Seibel N, Raetz EA, Pieters R, Horstmann MA, Relling MV, et al. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4376-84. PMID 18802149 DOI: 10.1200/Jco.2007.14.4519 |
0.439 |
|
| 2008 |
Willman CL, Kang H, Harvey RC, Chen I, Mullighan C, Downing JR, Relling MV, Zhang J, Gerhard D, Smith M, Dobbin KK, Reaman G, Hunger S. Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia. Blood. 112. DOI: 10.1182/Blood.V112.11.Sci-8.Sci-8 |
0.465 |
|
| 2008 |
Czuchlewski DR, Harvey RC, Chen I, Bourguet-Vincent A, Rodgers B, Vestal R, Ar K, Kang H, Wilson CS, Larsen EC, Hunger SP, Loh M, Devidas M, Raetz E, Reaman G, et al. Quantitative RT-PCR for Expression of a Small Subset of Genes Identifies Novel Prognostic Subgroups in High-Risk Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia (HR-ALL): Clinical Applicability of Gene Expression Microarray Data from Children’s Oncology Group Trials. Blood. 112: 1514-1514. DOI: 10.1182/BLOOD.V112.11.1514.1514 |
0.367 |
|
| 2007 |
Martin SB, Mosquera-Caro MP, Potter JW, Davidson GS, Andries E, Kang H, Helman P, Veroff RL, Atlas SR, Murphy M, Wang X, Ar K, Xu Y, Chen IM, Schultz FA, et al. Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia. Leukemia. 21: 1341-4. PMID 17410195 DOI: 10.1038/Sj.Leu.2404640 |
0.603 |
|
| 2007 |
Zeng W, Chen I, Tibbitts J, Kang H, Ar K, Atlas S, Willman CL. Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL). Blood. 110: 1432-1432. DOI: 10.1182/Blood.V110.11.1432.1432 |
0.395 |
|
| 2007 |
Harvey RC, Davidson GS, Wang X, Dobbin KK, Bedrick EJ, Wilson CS, Atlas SR, Kang H, Chen I, Hunger SP, Devidas M, Carroll WL, Bowman P, Camitta B, Reaman G, et al. Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study. Blood. 110: 1430-1430. DOI: 10.1182/Blood.V110.11.1430.1430 |
0.63 |
|
| 2007 |
Kang H, Bedrick EJ, Chen I, Wilson CS, Atlas SR, Harvey RC, Hunger SP, Devidas M, Borowitz MJ, Bowman P, Carroll WL, Camitta B, Reaman GH, Willman CL. Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric High-Risk B Precursor Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group Study. Blood. 110: 1422-1422. DOI: 10.1182/blood.v110.11.1422.1422 |
0.58 |
|
| 2006 |
Bhojwani D, Kang H, Moskowitz NP, Min DJ, Lee H, Potter JW, Davidson G, Willman CL, Borowitz MJ, Belitskaya-Levy I, Hunger SP, Raetz EA, Carroll WL. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 108: 711-7. PMID 16822902 DOI: 10.1182/Blood-2006-02-002824 |
0.418 |
|
| 2006 |
Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R, Ar K, Xu Y, Kopecky KJ, Ankerst DP, Gundacker H, Slovak ML, Mosquera-Caro M, Chen IM, Stirewalt DL, ... ... Kang H, et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood. 108: 685-96. PMID 16597596 DOI: 10.1182/Blood-2004-12-4633 |
0.426 |
|
| 2005 |
Willman CL, Kang H, Potter JW, Harvey RC, Atlas SR, Bedrick E, Helman P, Veroff RL, Chen I, Carroll AJ, Ar K, Xu Y, Murphy SB, Bhojwani D, Moskowitz N, et al. A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL). Blood. 106: 762-762. DOI: 10.1182/Blood.V106.11.762.762 |
0.653 |
|
| 2005 |
Zeng W, Chen I-, Xu Y, Potter J, Ar K, Kang H, Willman CL. Hematopoietic Cell Expression of OPAL1, an Outcome Predictor in Pediatric Acute Lymphoblastic Leukemia. Blood. 106: 1457-1457. DOI: 10.1182/Blood.V106.11.1457.1457 |
0.398 |
|
| 2005 |
Moskowitz NP, Bhojwani D, Kang H, Min D, Potter J, Harvey R, Seibel NL, Raetz E, Sather HN, Hunger SP, Willman CL, Carroll WL. Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL). Blood. 106: 1449-1449. DOI: 10.1182/Blood.V106.11.1449.1449 |
0.441 |
|
| Show low-probability matches. |